Contemporary Issues in Radiotherapy for Clinically Localized Prostate Cancer

被引:5
|
作者
Khor, Richard [1 ]
Williams, Scott [1 ]
机构
[1] Peter MacCallum Canc Ctr, Div Radiat Oncol & Canc Imaging, Melbourne, Vic 8006, Australia
关键词
Prostate carcinoma; Radiotherapy; Image-guided radiotherapy; Brachytherapy; Stereotactic body radiotherapy; DOSE-RATE BRACHYTHERAPY; EXTERNAL-BEAM RADIATION; PHASE-III TRIAL; QUALITY-OF-LIFE; 3-DIMENSIONAL CONFORMAL RADIOTHERAPY; ADJUVANT ANDROGEN DEPRIVATION; LOCALLY ADVANCED-CARCINOMA; SEMINAL-VESICLE INVASION; LYMPH-NODE DISSECTION; RADICAL PROSTATECTOMY;
D O I
10.1016/j.hoc.2013.08.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Radiotherapy is a valid curative alternative to surgery for prostate cancer. However, patient selection is critical to ensure patients obtain benefits from therapy delivered with curative intent. Dose-escalated radiation has been shown to improve patient outcomes, facilitated by development of robust image guidance and better target delineation imaging technologies. These concepts have also rekindled interest in hypofractionated radiotherapy in the forms of stereotactic body radiotherapy and brachytherapy. Postprostatectomy radiotherapy also improves long-term biochemical outcome in men at high risk of local recurrence.
引用
收藏
页码:1137 / +
页数:27
相关论文
共 50 条
  • [1] Comparing contemporary surgery to external-beam radiotherapy for clinically localized prostate cancer
    Zelefsky, MJ
    Leibel, SA
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) : 3363 - 3364
  • [3] CYBERKNIFE ROBOTIC HYPOFRACTIONATED RADIOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER
    Beltramo, G.
    Bianchi, L. C.
    Brait, L.
    Bergantin, A.
    Locatelli, F.
    Fariselli, L.
    Tombolini, P.
    Longo, G.
    Tabiadon, D.
    Locatelli, M. C.
    ANNALS OF ONCOLOGY, 2009, 20
  • [4] Urinary morbidity after radiotherapy for clinically localized prostate cancer
    Valgueblasse, Eddy
    Descazeaud, Aurelien
    PROGRES EN UROLOGIE, 2009, 19 (01): : F15 - F18
  • [5] Is there a "Curative" role of radiotherapy for clinically localized hormone refractory prostate cancer?
    Sanguineti, G
    Marcenaro, M
    Franzone, P
    Tognoni, P
    Barra, S
    Vitale, V
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (03): : 264 - 268
  • [6] Predictive Models in External Beam Radiotherapy for Clinically Localized Prostate Cancer
    Roach, Mack, III
    Waldman, Fred
    Pollack, Alan
    CANCER, 2009, 115 (13) : 3112 - 3120
  • [7] PSA AFTER DEFINITIVE RADIOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE-CANCER
    GOAD, JR
    CHANG, SJ
    OHORI, M
    SCARDINO, PT
    UROLOGIC CLINICS OF NORTH AMERICA, 1993, 20 (04) : 727 - 736
  • [8] Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer
    Yamazaki, Hideya
    Suzuki, Gen
    Aibe, Norihiro
    Shimizu, Daisuke
    Kimoto, Takuya
    Masui, Koji
    Yoshida, Ken
    Nakamura, Satoaki
    Hashimoto, Yasutoshi
    Okabe, Haruumi
    CANCERS, 2022, 14 (01)
  • [9] CONTEMPORARY TRENDS IN TREATMENT PATTERNS FOR MEN DIAGNOSED WITH CLINICALLY LOCALIZED PROSTATE CANCER
    Dalela, Deepansh
    Sammon, Jesse
    Sood, Akshay
    Jeong, Wooju
    Loeppenberg, Bjorn
    Karabon, Patrick
    Sun, Maxine
    Choueiri, Toni
    Menon, Mani
    Trinh, Quoc-Dien
    Abdollah, Firas
    JOURNAL OF UROLOGY, 2016, 195 (04): : E854 - E855
  • [10] Dose-escalated radiotherapy for clinically localized and locally advanced prostate cancer
    Kim, Sunghyun
    Kong, Jee Hyun
    Lee, YoHan
    Lee, Jun Young
    Kang, Tae Wook
    Kong, Tae Hoon
    Kim, Myung Ha
    You, Sei Hwan
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (03):